Shigetada Furukawa - Concepedia

Concepedia

Author

Shigetada Furukawa

Fujisawa City Hospital

Also Known As

SHIGETADA FURUKAWA, Shigetada Furukawa

26

Publications

7.6K

Citations

12

H-Index

36

Concepts

All Affiliations

Fujisawa City Hospital Astellas Pharma (Japan)The University of Osaka Japan Science and Technology Agency Mochida Pharmaceutical (Japan)

SF

About

Shigetada Furukawa is an author at Fujisawa City Hospital specializing in medicine, biochemistry, and microbiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	2K
2	Biochemistry	6	6	1.9K
3	Health Sciences	3	3	1.8K
4	Allergy	2	2	31
5	Cell Biology	2	2	1.2K

Shigetada Furukawa

×

15

Publications

7.6K

Citations

12

H-Index

	Year	Citations
Increased oxidative stress in obesity and its impact on metabolic syndrome Shigetada Furukawa, Takuya Fujita, Michio Shimabukuro, Journal of Clinical Investigation	2004	5.2K
Adipose Tissue Hypoxia in Obesity and Its Impact on Adipocytokine Dysregulation Naomi Hosogai, Atsunori Fukuhara, Kazuya Oshima, Diabetes Metabolic DisorderAdipokinesInsulin SignalingObesityInflammation	2007	1.2K
Increased oxidative stress in obesity and its impact on metabolic syndrome Shigetada Furukawa, Takuya Fujita, Michio Shimabukuro, Journal of Clinical Investigation Metabolic DisorderNadph OxidaseFatty Liver DiseaseOxidative StressObesity	2004	600
Taxonomy, Fermentation, Isolation and Biological Activities. Hiroaki Mori, Yasuharu Urano, Fumie Abe, The Journal of Antibiotics	2003	235
ASP2397: a novel antifungal agent produced by Acremonium persicinum MF-347833 Ikuko Nakamura, Seiji Yoshimura, Teruhisa Masaki, The Journal of Antibiotics Antifungal AgentAntifungal AgentsBiotechnologyMedicinal FungiMicrobiology	2016	83
Discovery of a new antifungal agent ASP2397 using a silkworm model of Aspergillus fumigatus infection Ikuko Nakamura, Ryuichi Kanasaki, Koji Yoshikawa, The Journal of Antibiotics Aspergillus Fumigatus InfectionAntifungal AgentSilkworm ModelAntifungal AgentsMicrobiology	2016	76
Biological Activities in Animal Models. Hiroaki Mori, Fumie Abe, Satoko Furukawa, The Journal of Antibiotics	2003	42
FR235222, a fungal metabolite, is a novel immunosuppressant that inhibits mammalian histone deacetylase (HDAC) II. Biological activities in animal models. Hiroaki Mori, Fumie Abe, Satoko Furukawa, PubMed	2003	39
FR258900, a Novel Glycogen Phosphorylase Inhibitor Isolated from Fungus No. 138354 Shigetada Furukawa, Kana Murakami, MOTOAKI NISHIKAWA, The Journal of Antibiotics Fungus NoCellular EnzymologyBiochemistryMicrobiologyGlycosylation	2005	20
Anti-IL-23 receptor monoclonal antibody prevents CD4+ T cell-mediated colitis in association with decreased systemic Th1 and Th17 responses Emiko Imamura, Katsunari Taguchi, Haruna Sasaki-Iwaoka, European Journal of Pharmacology InflammationAllergyT-regulatory CellImmunologyAutoimmunity	2018	20

Page 1